Cite

HARVARD Citation

    Fuh, F. et al. (n.d.). Etrolizumab Treatment Modulates MAdCAM‐1 Levels in Serum in Ulcerative Colitis Patients. American journal of gastroenterology. p. . [Online]. 
  
Back to record